Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
Irreversible inhibition of cytosolic thioredoxin reductase 1 as a mechanistic basis for anticancer therapy.
Journal: Science translational medicine
Published: March 23, 2016
Indolin-2-one compounds targeting thioredoxin reductase as potential anticancer drug leads.
Journal: Oncotarget
Published: October 28, 2015
Redox effects and cytotoxic profiles of MJ25 and auranofin towards malignant melanoma cells.
Journal: Oncotarget
Published: December 15, 2014
The 19S Deubiquitinase inhibitor b-AP15 is enriched in cells and elicits rapid commitment to cell death.
Journal: Molecular pharmacology
Published: April 10, 2014
Showing 1-4 of 4
Last Updated: 09/26/2026